Switch to:

GuruFocus Financial Strength Rank measures how strong a company’s financial situation is. It is based on these factors

1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

Financial Strength : 7/10

vs
industry
vs
history
Cash to Debt No Debt
MBLX's Cash to Debt is ranked higher than
99% of the 1007 Companies
in the Global Specialty Chemicals industry.

( Industry Median: 0.60 vs. MBLX: No Debt )
Ranked among companies with meaningful Cash to Debt only.
MBLX' s 10-Year Cash to Debt Range
Min: 9.28  Med: 10000.00 Max: No Debt
Current: No Debt
Equity to Asset 0.80
MBLX's Equity to Asset is ranked higher than
89% of the 866 Companies
in the Global Specialty Chemicals industry.

( Industry Median: 0.53 vs. MBLX: 0.80 )
Ranked among companies with meaningful Equity to Asset only.
MBLX' s 10-Year Equity to Asset Range
Min: -6.36  Med: 0.66 Max: 0.95
Current: 0.8
-6.36
0.95
Interest Coverage No Debt
MBLX's Interest Coverage is ranked higher than
98% of the 564 Companies
in the Global Specialty Chemicals industry.

( Industry Median: 48.18 vs. MBLX: No Debt )
Ranked among companies with meaningful Interest Coverage only.
MBLX' s 10-Year Interest Coverage Range
Min: 9999.99  Med: 10000.00 Max: 9999.99
Current: No Debt
F-Score: 5
Z-Score: -16.25
M-Score: -4.36
GuruFocus Profitability Rank ranks how profitable a company is and how likely the company’s business will stay that way. It is based on these factors:

1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
••3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rank•

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength Rank. But if a company is consistently profitable, its financial strength will be stronger.

Profitability & Growth : 5/10

vs
industry
vs
history
Operating margin (%) -776.11
MBLX's Operating margin (%) is ranked lower than
98% of the 992 Companies
in the Global Specialty Chemicals industry.

( Industry Median: 5.20 vs. MBLX: -776.11 )
Ranked among companies with meaningful Operating margin (%) only.
MBLX' s 10-Year Operating margin (%) Range
Min: -8691.74  Med: -856.81 Max: 8.51
Current: -776.11
-8691.74
8.51
Net-margin (%) -824.25
MBLX's Net-margin (%) is ranked lower than
98% of the 993 Companies
in the Global Specialty Chemicals industry.

( Industry Median: 3.70 vs. MBLX: -824.25 )
Ranked among companies with meaningful Net-margin (%) only.
MBLX' s 10-Year Net-margin (%) Range
Min: -8661.38  Med: -807.46 Max: 8.58
Current: -824.25
-8661.38
8.58
ROE (%) -177.34
MBLX's ROE (%) is ranked lower than
99% of the 980 Companies
in the Global Specialty Chemicals industry.

( Industry Median: 6.99 vs. MBLX: -177.34 )
Ranked among companies with meaningful ROE (%) only.
MBLX' s 10-Year ROE (%) Range
Min: -150.71  Med: -66.51 Max: 8.36
Current: -177.34
-150.71
8.36
ROA (%) -139.76
MBLX's ROA (%) is ranked lower than
99% of the 1015 Companies
in the Global Specialty Chemicals industry.

( Industry Median: 3.58 vs. MBLX: -139.76 )
Ranked among companies with meaningful ROA (%) only.
MBLX' s 10-Year ROA (%) Range
Min: -518.55  Med: -49.53 Max: 5.32
Current: -139.76
-518.55
5.32
ROC (Joel Greenblatt) (%) -2750.54
MBLX's ROC (Joel Greenblatt) (%) is ranked lower than
99% of the 1009 Companies
in the Global Specialty Chemicals industry.

( Industry Median: 9.92 vs. MBLX: -2750.54 )
Ranked among companies with meaningful ROC (Joel Greenblatt) (%) only.
MBLX' s 10-Year ROC (Joel Greenblatt) (%) Range
Min: -4296.08  Med: -722.54 Max: 198.29
Current: -2750.54
-4296.08
198.29
EBITDA Growth (3Y)(%) -29.00
MBLX's EBITDA Growth (3Y)(%) is ranked lower than
91% of the 700 Companies
in the Global Specialty Chemicals industry.

( Industry Median: 2.10 vs. MBLX: -29.00 )
Ranked among companies with meaningful EBITDA Growth (3Y)(%) only.
MBLX' s 10-Year EBITDA Growth (3Y)(%) Range
Min: 0  Med: -11.90 Max: 4.6
Current: -29
0
4.6
EPS Growth (3Y)(%) -29.20
MBLX's EPS Growth (3Y)(%) is ranked lower than
86% of the 634 Companies
in the Global Specialty Chemicals industry.

( Industry Median: 3.20 vs. MBLX: -29.20 )
Ranked among companies with meaningful EPS Growth (3Y)(%) only.
MBLX' s 10-Year EPS Growth (3Y)(%) Range
Min: -29.2  Med: -7.70 Max: 4.6
Current: -29.2
-29.2
4.6
» MBLX's 10-Y Financials

Financials


Revenue & Net Income
Cash & Debt
Oprt. Cash Flow & Free Cash Flow

» Details

Guru Trades

Q4 2013

MBLX Guru Trades in Q4 2013

Jim Simons 67,500 sh (+34.69%)
» More
Q1 2014

MBLX Guru Trades in Q1 2014

Jim Simons 51,900 sh (-23.11%)
» More
Q2 2014

MBLX Guru Trades in Q2 2014

Jim Simons 56,507 sh (+8.88%)
» More
Q3 2014

MBLX Guru Trades in Q3 2014

Jim Simons Sold Out
» More
» Details

Insider Trades

Latest Guru Trades with MBLX

(List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)

No Entry found in the selected group of Gurus. You can
  • 1. Modify your Personalized List of Gurus, or
  • 2. Click on Premium Premium Tools above to check out all the Gurus, or
  • 3. Click on Premium Plus Premium Plus above for the stocks picks of all the institutional investment advisors (>4000)
» Interactive Charts

Peter Lynch Chart ( What is Peter Lynch Charts )

Ratios

vs
industry
vs
history
P/B 5.52
MBLX's P/B is ranked lower than
87% of the 948 Companies
in the Global Specialty Chemicals industry.

( Industry Median: 1.66 vs. MBLX: 5.52 )
Ranked among companies with meaningful P/B only.
MBLX' s 10-Year P/B Range
Min: 0.69  Med: 3.51 Max: 18.59
Current: 5.52
0.69
18.59
P/S 16.00
MBLX's P/S is ranked lower than
94% of the 986 Companies
in the Global Specialty Chemicals industry.

( Industry Median: 1.05 vs. MBLX: 16.00 )
Ranked among companies with meaningful P/S only.
MBLX' s 10-Year P/S Range
Min: 0.94  Med: 102.55 Max: 742.5
Current: 16
0.94
742.5
EV-to-EBIT -2.35
MBLX's EV-to-EBIT is ranked lower than
159% of the 782 Companies
in the Global Specialty Chemicals industry.

( Industry Median: 15.74 vs. MBLX: -2.35 )
Ranked among companies with meaningful EV-to-EBIT only.
MBLX' s 10-Year EV-to-EBIT Range
Min: -114.7  Med: -3.20 Max: 18.4
Current: -2.35
-114.7
18.4
Current Ratio 4.84
MBLX's Current Ratio is ranked higher than
92% of the 877 Companies
in the Global Specialty Chemicals industry.

( Industry Median: 1.73 vs. MBLX: 4.84 )
Ranked among companies with meaningful Current Ratio only.
MBLX' s 10-Year Current Ratio Range
Min: 1.43  Med: 10.95 Max: 38.31
Current: 4.84
1.43
38.31
Quick Ratio 4.66
MBLX's Quick Ratio is ranked higher than
94% of the 877 Companies
in the Global Specialty Chemicals industry.

( Industry Median: 1.19 vs. MBLX: 4.66 )
Ranked among companies with meaningful Quick Ratio only.
MBLX' s 10-Year Quick Ratio Range
Min: 1.43  Med: 10.92 Max: 38.31
Current: 4.66
1.43
38.31
Days Inventory 371.20
MBLX's Days Inventory is ranked lower than
98% of the 969 Companies
in the Global Specialty Chemicals industry.

( Industry Median: 65.62 vs. MBLX: 371.20 )
Ranked among companies with meaningful Days Inventory only.
MBLX' s 10-Year Days Inventory Range
Min: 308.72  Med: 410.05 Max: 490.21
Current: 371.2
308.72
490.21
Days Sales Outstanding 19.23
MBLX's Days Sales Outstanding is ranked higher than
89% of the 831 Companies
in the Global Specialty Chemicals industry.

( Industry Median: 58.66 vs. MBLX: 19.23 )
Ranked among companies with meaningful Days Sales Outstanding only.
MBLX' s 10-Year Days Sales Outstanding Range
Min: 4.87  Med: 37.40 Max: 681.12
Current: 19.23
4.87
681.12

Valuation & Return

vs
industry
vs
history
Price/Net Cash 7.34
MBLX's Price/Net Cash is ranked higher than
58% of the 90 Companies
in the Global Specialty Chemicals industry.

( Industry Median: 10.50 vs. MBLX: 7.34 )
Ranked among companies with meaningful Price/Net Cash only.
MBLX' s 10-Year Price/Net Cash Range
Min: 1.35  Med: 4.89 Max: 30.71
Current: 7.34
1.35
30.71
Price/Net Current Asset Value 5.98
MBLX's Price/Net Current Asset Value is ranked lower than
55% of the 385 Companies
in the Global Specialty Chemicals industry.

( Industry Median: 5.44 vs. MBLX: 5.98 )
Ranked among companies with meaningful Price/Net Current Asset Value only.
MBLX' s 10-Year Price/Net Current Asset Value Range
Min: 1.19  Med: 4.28 Max: 23.53
Current: 5.98
1.19
23.53
Price/Tangible Book 5.47
MBLX's Price/Tangible Book is ranked lower than
83% of the 906 Companies
in the Global Specialty Chemicals industry.

( Industry Median: 1.78 vs. MBLX: 5.47 )
Ranked among companies with meaningful Price/Tangible Book only.
MBLX' s 10-Year Price/Tangible Book Range
Min: 1.01  Med: 3.65 Max: 18.28
Current: 5.47
1.01
18.28
Price/Median PS Value 0.09
MBLX's Price/Median PS Value is ranked higher than
100% of the 849 Companies
in the Global Specialty Chemicals industry.

( Industry Median: 1.17 vs. MBLX: 0.09 )
Ranked among companies with meaningful Price/Median PS Value only.
MBLX' s 10-Year Price/Median PS Value Range
Min: 0.01  Med: 1.10 Max: 7.12
Current: 0.09
0.01
7.12
Earnings Yield (Greenblatt) (%) -42.57
MBLX's Earnings Yield (Greenblatt) (%) is ranked lower than
98% of the 996 Companies
in the Global Specialty Chemicals industry.

( Industry Median: 4.40 vs. MBLX: -42.57 )
Ranked among companies with meaningful Earnings Yield (Greenblatt) (%) only.
MBLX' s 10-Year Earnings Yield (Greenblatt) (%) Range
Min: -41.2  Med: 22.60 Max: 765.1
Current: -42.57
-41.2
765.1

Business Description

Industry: Chemicals » Specialty Chemicals
Compare:NEU, SCL, VAL, POL, CYT » details
Traded in other countries:M6X1.Germany,
Metabolix Inc was incorporated in Massachusetts in June 1992 under the name Metabolix, Inc. In September 1998, it reincorporated in Delaware. The Company is an innovation-driven bioscience company focused on delivering sustainable solutions to the plastics and chemicals industries. It is engaged in products and markets development of a biopolymer platform, based on technology developed by the Company and early commercialization efforts conducted through the Telles joint venture with ADM. The Company has its operations in U.S. and Canada. It has core capabilities in microbial genetics, fermentation process engineering, chemical engineering, polymer science, plant genetics and botanical science, and has assembled these capabilities in a way that has allowed the Company to integrate its biotechnology research with real world chemical engineering and industrial practice. It has created an intellectual property portfolio to protect its innovations and, together with its technology, to serve as a valuable foundation for future industry collaborations. It has focused on a family of biopolymers found in nature called polyhydroxyalkanoates "PHA", which occur naturally in living organisms and are chemically similar to polyesters. It has demonstrated the production of PHAs at industrial scale to produce PHA biopolymers and PHA precursors to biobased industrial chemicals. It has also demonstrated the production of polyhydroxybutyrate, a subclass of PHAs, in agriculturally significant non-food crops. Polymers are found in nature in a range of organisms including microbes, plants and animals. The Company competes with Dow Chemical, DuPont, BASF, Ineos, LyondellBasell, SABIC, Mitsubishi Chemical, DuPont, DSM, Arkema and Braskem. The Company is subject to significant foreign and domestic government regulations, and compliance or failure to comply with these regulations could harm its business.
» More Articles for MBLX

Headlines

Articles On GuruFocus.com
5 Biggest Losers of Magic Formula Investing in 2013 Dec 18 2013 
comment on MBLX Sep 25 2012 
comment on MBLX Aug 07 2012 
METABOLIX, INC. Reports Operating Results (10-K) Mar 10 2011 
Market Neutral Trade for 2.10.2011: Long EMN, Short MBLX Feb 10 2011 
METABOLIX, INC. Reports Operating Results (10-Q) Nov 09 2010 
METABOLIX, INC. Reports Operating Results (10-Q) Jul 29 2010 
METABOLIX, INC. Reports Operating Results (10-Q) May 03 2010 
METABOLIX, INC. Reports Operating Results (10-Q) Nov 03 2009 
METABOLIX, INC. Reports Operating Results (10-Q) Aug 06 2009 

More From Other Websites
Metabolix to Conduct Webcast of Its Second Quarter 2015 Earnings Call Aug 03 2015
Metabolix to Conduct Webcast of Its Second Quarter 2015 Earnings Call Aug 03 2015
METABOLIX, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Other Events,... Jun 17 2015
Metabolix, Inc. Announces $15 Million Equity Private Placement Jun 16 2015
Metabolix, Inc. Announces $15 Million Equity Private Placement Jun 16 2015
Metabolix to Exhibit Innovations in Building Materials at Profiles 2015 Jun 08 2015
Metabolix to Exhibit Innovations in Building Materials at Profiles 2015 Jun 08 2015
Metabolix to Present Sustainability Innovations in Personal Care Products and Packaging at HBA... Jun 04 2015
Metabolix to Present Sustainability Innovations in Personal Care Products and Packaging at HBA... Jun 04 2015
METABOLIX, INC. Files SEC form 8-K, Submission of Matters to a Vote of Security Holders Jun 01 2015
METABOLIX, INC. Financials May 29 2015
METABOLIX, INC. Files SEC form 8-K, Material Modification to Rights of Security Holders, Amendments... May 26 2015
Metabolix Announces 1-for-6 Reverse Stock Split May 26 2015
Metabolix Announces 1-for-6 Reverse Stock Split May 26 2015
10-Q for Metabolix, Inc. May 16 2015
METABOLIX, INC. Files SEC form 10-Q, Quarterly Report May 14 2015
Metabolix Announces First Quarter 2015 Financial Results May 13 2015
Metabolix reports 1Q loss May 13 2015
Metabolix reports 1Q loss May 13 2015
Metabolix Inc Earnings Call scheduled for 4:30 pm ET today May 13 2015

Personalized Checklist

Checklist has been moved to "Checklist" tab.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
FEEDBACK